Review
Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics Molecular imaging of living subjects is an emerging field that aims to study molecular and cellular events in the intact living animal and human [1] . In comparison to classical diagnostic imaging, it sets forth to probe the molecular abnormalities that are the basis of disease rather than to image the end effects of these molecular alterations. To tackle this task, most molecular imaging techniques rely on the design of suitable probes that report on the physiopathological processes of interest.
The application of innovative nanotechnologies to medicine, nanomedicine, has the potential to significantly benefit clinical practice, offering solutions to many of the current limitations in diagnosis, treatment and management of human diseases [2] [3] [4] [5] . Owing to their very high transverse relaxivity, colloidal suspensions of superparamagnetic nanocrystals are very good candidates for the development of new molecular imaging probes, allowing for an early detection of several pathologies [6] [7] [8] . However, their hydrophobicity or poor colloidal stability at physiological conditions frequently renders them inappropriate for clinical use. To stabilize them, different methods and coatings consisting of either polymers [9] [10] [11] [12] or amphiphilic molecules, such as fatty acids [13] and phospholipids [14] [15] [16] [17] [18] [19] , are used. Phospholipid coatings are gaining much interest owing to their inherent properties providing several advantages, such as biocompatibility, biodegradability and reduced toxicity [20] .
Amphiphilic aggregates
Phospholipids or surfactants are molecules that contain both a hydrophobic (nonpolar chain) and a hydrophilic (polar head) part ( Figure 1A) . In aqueous media, amphiphilic compounds selfassociate into aggregates with different sizes and geometries because of their dual character. There is a wide variety in both the hydrophobic and hydrophilic parts of amphiphilic molecules. The hydrophobic tail can vary in length and can also consist of multiple chains, which lead to different ratios between the size of the hydrophobic and hydrophilic parts ( Figure 1A ). These characteristics and other parameters, such as concentration, temperature and pH, lead to different aggregates in aqueous solution. The length and the size of the hydrophobic chain(s) determine the curvature of the aggregate and whether a micelle-like or bilayer-like structure will be formed. Depending on the concentration, a wide variety of structures are possible [14, 21] .
Some of the aggregates for in vivo applications are shown in Figure 1B . Liposomes are closed spherical vesicles consisting of a phospholipid bilayer that encapsulates an aqueous phase in which drugs can be stored. Pursuing different in vivo delivery purposes, the size,
In the emerging field of molecular and cellular imaging, flexible strategies to synthesize multimodal contrast agents with targeting ligands are required. Liposomes have the ability to combine with a large variety of nanomaterials, including superparamagnetic iron oxide nanoparticles, to form magnetoliposomes (MLs). MLs can be used as highly efficient MRI contrast agents. Owing to their high flexibility, MLs can be associated with other imaging modality probes to be used as multimodal contrast agents. By using a thermosensitive lipid bilayer in the ML structure, these biocompatible systems offer many possibilities for targeting and delivering therapeutic agents for 'theragnostics', a coincident therapy and diagnosis strategy. This article deals with the fast-growing field of MLs as biomedical diagnostic tools. Different kinds of MLs, their preparation methods, as well as their surface modification with different imaging probes, are discussed. ML applications as multimodal contrast agents and in theragnostics are reviewed. Some important issues for the biomedical uses of magnetic liposomes, such as toxicity, are summarized.
future science group Review Fattahi, Laurent, Liu, Arsalani, Vander Elst & Muller charge and surface properties of liposomes can be easily changed, simply by adding new ingredients to the lipid mixture before liposome preparation or by variation of the preparation methods. Hydrophilic polymers, such as polyethylene gylcol (PEG), can be attached onto the liposome surface to sterically stabilize and increase blood circulation residence time [22] . Also, targeting ligands (e.g., antibodies or peptides) can be attached to increase the l iposome specificity toward target tissues [19, 23] .
Another class of lipid aggregates is selfassemblies of lipid mono-or bi-layers that contain a solid core. When iron oxide nanoparticles are encapsulated by liposomes, the general term 'magnetoliposomes' (MLs) is used for the resulting colloidal structures [24] . In this article, we highlight various types of MLs, their preparation, their physicochemical characterization, and their application as molecular imaging probes and in theragnostics. Some details about biological issues of MLs, such as toxicity, are reviewed.
Different types of MLs & their preparation
Depending on their structure, there are generally two kinds of MLs, known as classical and extruded MLs. Figure 2 shows the schematic representation of these two kinds of MLs. In the first kind, usually known as classical MLs, each individual iron oxide nanoparticle is surrounded by a bilayer of phospholipid. This kind of ML was first prepared by De Cuyper et al. [15] , and has a magnetic core of 14 nm. Different types of phosphatidylglycerols are used to form the liposomes. The overall size of the MLs is approximately 20 nm. For the preparation of these classical MLs, magnetite nanoparticles were first stabilized with lauric acid and then sonicated phospholipid dispersions were added to the lauric acid-coated magnetite suspension. Physicochemical characterizations have shown that phospholipids, which form the inner monolayer of MLs, are chemisorbed very quickly and strongly with their charged head group [25] , while the outer layer assembles through Van der [26] . In a successful protocol, neutral MLs were first prepared from zwitterionic phosphatidylcholine vesicles and anionically stabilized magnetic fluid, and these neutral MLs were then incubated with cationic vesicles formed from phosphatidylcholine and dioleyltrimethylammoniumpropane. During the second step, intermembrane lipid transfer occurs and after an equilibrium state, the separation of cationic MLs was performed by high-gradient m agnetophoresis (Figure 4) [26, 27] .
The second type of magnetoliposomes, described more recently and known as extruded MLs, consists of large unilamellar vesicles, which encompass several iron oxide nanoparticles in their aqueous central space [28, 29] . The mean size of these liposomes is approximately 200 nm, and the size of the iron oxide nanoparticles is 1-10 nm. Various concentrations of iron oxide nanoparticles can be used to obtain different final concentrations in the liposomes. In order to prepare this kind of ML, first -to avoid the aggregation of particles -nanoparticles are treated with a surfactant, which results in a stable ferrofluid suspension. Then obtained ferrofluid is used to hydrate the phospholipid layers and final dispersion, after homogenizing, is extruded through polycarbonate membranes under nitrogen pressure to obtain extruded MLs. By using a membrane with a different pore size, it is possible to prepare MLs of a different size. Owing to extrusion through membranes with specific pore size, these MLs are homogeneous in size (195 ± 33 nm hydrodynamic diameters from quasi-elastic light scattering) [28] . Another advantage of these extruded MLs is that besides an iron oxide core, other hydrophilic drugs can be captured in the inner aqueous space of the liposome, so that this system, as will be explained in the coming sections, can be used in theragnostics (combination of diagnosis and therapy) [30] [31] [32] . Figure 5 shows the TEM image of these MLs. The entrapped iron oxide nanocrystals can be observed clearly inside the liposome.
The smaller size of the iron oxide cores in extruded MLs may lead to reduced magnetic properties compared with those of classical MLs. However, when the iron load of the cells is high enough, these extruded MLs can have adequate magnetic properties, which make them a highly efficient T 2 contrast agent for MRI [28] .
MLs as MRI contrast agents
MRI ranks among the best noninvasive methodologies that allow the identification and characterization of pathological tissues and lesions [33] . Its main advantages are that it allows rapid in vivo image acquisition and, depending on the scanner and contrast agents, it makes possible imaging at single-cell resolution. The principle of this technique is based on the application of The image results from the spatial identification of hydrogen nuclei. This image is constituted of elements, 'pixels', where gray levels represent the signal intensity emitted by corresponding volume elements, 'voxels'. The contrast comes from local differences in spin relaxation kinetics along the longitudinal T 1 (spin-lattice) and transverse T 2 (spin-spin) relaxation times. On this basis, endogenous contrast depends on the chemical and physical nature of the tissues and often arises from local variation in proton density (water concentration) [34] . Otherwise, exogenous substances or contrast agents that alter signal intensity by selectively shortening the hydrogen relaxation times of the tissues are used to improve the sensitivity and specificity of MRI. The relaxivity for a MRI contrast agent is defined as the increase of the relaxation rate of the solvent (water) induced by 1 mmol/l of the active ion Step 2
Step 1 Figure 4 . Production of cationic magnetoliposomes. Briefly, neutral vesicles were dialyzed with lauric acid-stabilized magnetic fluid against TES buffer (5 mm, pH 7.0). Separation of the resulting magnetoliposomes (MLs) from excess vesicles was performed by high-gradient magnetophoresis, which is represented schematically in the insert. Neutral MLs were then incubated with cationic lipid-containing vesicles, which resulted in the production of cationic MLs. Insert shows a transmission electron microscopy micrograph of the ML structures.
Reprinted with permission from [27] .
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). In the last decades, the chemistry of contrast agents for MRI has developed significantly [35, 36] . Paramagnetic complexes, mainly gadolinium derivatives and chemical-exchange saturation transfer (CEST) agents have received particular attention, which typically behave as T 1 (positive) contrast agents [37] [38] [39] [40] . Besides, superparamagnetic iron oxide (SPIO) nanoparticles have emerged as T 2 contrast agents, which permit negative contrast enhancement and, thus, darker images of the regions of interest. Also, in recent years, iron oxide nanoparticles have been used as T 1 contrast agents [41] [42] [43] . As mentioned previously, to overcome the hydrophobicity or poor colloidal stability of these nanoparticles in physiological conditions, different coatings are used. The most widely applied coatings are dextran and carboxydextran. However, dextrancoated nanoparticles have been criticized for several reasons, including allergic reactions (occasionally) [44] , limitations in surface modification for efficient internalization because of weak physisorption of dextran onto the nanoparticles' surface [45] , and degradation of dextran to lysosomes in the body, leading to exposure of naked iron oxide, which induces cytotoxic effects [46] .
Considering the previously listed characteristics of phospholipids, including biocompatibility and strong binding on the particle's surface, several of the abovementioned problems can be circumvented using MLs as MRI contrast agents [47, 48] .
Extruded MLs can act as an efficient MRI contrast agent with enhancing T 2 contrast. For these MLs, the ratios of the transverse (r 2 ) and longitudinal (r 1 ) magnetic resonance (MR) relaxivities of water protons is between 6 and 18, which ranks them among the best T 2 contrast agents. T 2 contrast enhancement is related to the amount of iron loading, which increases by high loading of iron in MLs [28] . In addition, these MLs have been targeted successfully to solid tumors by applying an external magnet above one flank of Swiss mice bearing a PC3 human prostate carcinoma tumor in each flank. They led to a 52% contrast enhancement in magnetically targeted tumor, while there was only 7% enhancement in the nontargeted tumor [49] .
Classical MLs have also been used as an excellent bone marrow-seeking MRI contrast agent [50] . PEGylated MLs were prepared with a diameter of 40 nm and contained one to six SPIO crystals per liposome. The r 1 and r 2 relaxivities were 3 and 240 s , respectively, at 1.5 T, an unusually high ratio of r 2 /r 1 (80) that ranks them as one of the best MRI T 2 contrast agents. MRI showed that, in addition to the liver, there was a noticeable uptake of the injected MLs in bone marrow, including the iliac bone, femur, tibia and lower vertebrae (Figure 6 ). Among the different pulse sequences used, fast-spin echo (FSE) imaging was found to provide the best contrast enhancement and image quality. The bone marrow uptake reached a plateau within the first 30 min following injection, since there were no differences in signal intensities between the first (30 min) and second (1 h) postinjection scans [50] .
De Cuyper et al. have used MLs to combine the T 1 (positive) and T 2 (negative) MRI contrast agents in a unique system to obtain bilabel contrast agents [51, 52] . Gadolinium ions were Reprinted with permission from [28] . Reprinted with permission from [50] .
future science group β-BODIPY FL C 5 -HPC: 2-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine; DMPC: Dimyristoylphosphatidylcholine; DPPE: Dipalmitoylphosphatidylethanolamine; DSTAP: 1,2-distearoyl-3-trimethylammonium-propane. Modified with permission from [55] . 
MLs as multimodal imaging contrast agents
Multimodality molecular imaging is now playing a pivotal role in biomedical research. Multimodality imaging is emerging as a technology that utilizes the strengths of different modalities and yields a hybrid imaging platform with benefits superior to those of any of its i ndividual components [53] .
The commonly used imaging modalities include MRI, x-ray computed tomography (CT), PET, single-photon emission CT (SPECT) and ultrasound. Several new promising imaging modalities, such as fluorescence-mediated tomography, optical coherence tomo graphy and photo acoustic tomography are being developed [54] . Each of these diagnostic modalities has its advantages and disadvantages. For example, MRI and CT have high spatial resolution and are able to provide detailed anatomical information, but they lack sensitivity. Alternatively, PET and SPECT are highly sensitive, but have limited resolution and cannot provide anatomical information. Thus, multimodality imaging techniques, such as PET/CT, MRI optical and MRI/PET, overcome the limitations of individual imaging modalities [28] . In view of the wide versatility in lipid types and lipid conjugation, MLs can be constructed to serve as a multimodality contrast agent, thus c ontributing to the benefits of these imaging techniques.
The flexible nature of the ML coatings, together with the simple production procedure, allow rapid and easy modification of the coating, offering many exciting applications as multimodal contrast agents. Figure 7 shows a scheme of different strategies for labeling the ML lipid bilayers with different fluorophores as bimodal contrast agents for MRI/optical imaging. As clear from this figure, fluorescently tagged lipid conjugates can be easily incorporated into either of the ML layers by simple modification of the production procedure. In addition, this modification can be conducted easily on either neutral or cationic MLs. To label the inner layer, a lipid with a fluorescent tag located at the end of a truncated fatty acyl chain has been chosen, as this configuration will not hinder the strong anchoring of the phospholipids on the iron oxide surface. By contrast, to label the outer layer, it is better to work with the fluorescent moiety in the polar head-group region so that it can freely protrude into the surrounding medium [55] .
Van Tilborg et al. have designed annexin A5-functionalized MLs as bimodal contrast agents for detection of apoptosis [56] . 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (PE-carboxyfluorescein) was introduced into the lipid bilayer as a probe Reprinted with permission from [56] .
future science group Figure 8 shows the preparation steps of this bimodal contrast agent. This functionalization of MLs with annexin A5 molecules enabled the detection of apoptotic T-lymphoma cell line (Jurkat cells) by both fluorescence and MRI (Figure 9 ). The use of these bimodal MLs allowed further evaluation of the in vivo biodistribution and pharmacokinetics of the particles and also the effect of PEGylation. The pharmacokinetic profile was characterized by two first-order k inetics of elimination with distinct plasmatic half-lives of 70 min and 12.5 h for non-PEGylated and PEGylated MLs, respectively [57] .
The interaction of MLs with human adenocarcinoma prostatic cell line PC3 has been studied in vitro by the addition of fluorescent probes [58] . The results show that by using this bimodal contrast agent and the two complementary techniques, fluorescence microscopy and magnetophoresis, it was possible to assess that PEGylated MLs strongly interact with PC3 cancer cells (Figure 10 ).
MLs as cancer nanotheragnostics
Theragnostics is a strategy that integrates therapeutics with diagnostics to develop new personalized treatments with enhanced efficacy and safety [59] . Recently, nanotechnology and molecular imaging have been combined to generate multifunctional nanoparticles that facilitate cancer theragnostics [60, 61] . Theragnostic nanoparticles (nanotheragnostics )show great promise in the emerging field of personalized medicine, because they allow detection of an individual patient's cancer at an early stage, and can be used to deliver anticancer agents over an extended period for enhanced therapeutic efficacy. Moreover, real-time, noninvasive monitoring of the theragnostic nanoparticles enables clinicians to rapidly decide whether the regimen is effective or not in an individual patient [62] . For these reasons, cancer theragnostics with multifunctional nanoparticles presents a promising new strategy in cancer treatment. Successful clinical applications of cancer theragnostics require the discovery of highly efficient tumor-homing nanoparticles, which can diagnose and deliver targeted therapy [63] [64] [65] [66] [67] .
It appears to be that MLs are versatile theragnostics systems, owing to their biocompatibility, chemical functionality and the potential they offer for combining drug delivery and hyperthermia treatment of cancers [18, [68] [69] [70] . MLs, used as drug carriers, can be made to accumulate in a target tissue such as a tumor by a strong permanent gradient magnetic field, a concept which is known as magnetic drug targeting. Using a special lipid composition for MLs, so-called thermosensitive MLs with tumor-targeting ligand, the release of the loaded drug can be controlled by reaching a critical temperature [71, 72] . This critical temperature can be achieved by applying an alternating magnetic field, which is used for cancer hyperthermia treatment in conjunction with chemotherapy [73, 74] . Results show that both the magnetic nanoparticles and anticancer drugs, such as doxorubicin, can be successfully encapsulated within the liposomes with high encapsulation efficiency (Figure 11 ). Taken together, the multifunctional properties of MLs enabled improved tumor cell killing in comparison to nonmagnetic folate-targeted liposomes and Caelyx ® , a stealth liposomal formulation of doxorubicin approved for clinical use [74] . Given the efficiency of iron oxide nanoparticles as T 2 contrast agent, the whole treatment process can be monitored by MRI.
In recent years, several polymeric magnetic micelles that show high potential for cancer theragnostics have also been prepared. These theragnostic systems include Pluronic-stabilized magnetic micelles [75, 76] , thermally cross-linked iron oxide nanoparticles [77, 78] , anionic surfactantstabilized micelles [79] , cationic polymer-stabilized micelles [80] or stimuli-adaptable micelles [81] . Reprinted with permission from [56] .
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Specifically, Yang et al. have prepared multifunctional worm-like vesicles loaded simultaneously with SPIO nanoparticles and doxorubicin for targeted cancer therapy and ultrasensitive MRI [82] . These worm-like polymer vesicles were formed by heterobifunctional triblock copolymers R(methoxy or FA)-PEG 114 -PLA x -PEG 46 -acrylate via a double emulsion method. The long PEG segments bearing methoxy/folate groups (CH 3 O/FA-PEG 114 ) were mostly segregated to the outer hydrophilic PEG layers of the wormlike vesicles, thereby providing an active tumortargeting ability; while the short PEG segments bearing acrylate groups (PEG46-acrylate) were mostly segregated onto the inner hydrophilic PEG layers of the worm-like vesicles, thereby allowing the inner PEG layers to be crosslinked via free radical polymerization for enhanced in vivo stability (Figure 12) . The doxorubicin and SPIO loading level was 9.0 and 48.0 wt%, respectively, both of which can be adjusted if necessary. These multifunctional worm-like vesicles demonstrated a much higher r 2 relaxivity value than Feridex ® , a fact that can be attributed to the high SPIO nanoparticle loading level, as well as the SPIO clustering effect.
The drug-release behavior of SPIO/doxorubicin-loaded crosslinked and noncrosslinked worm-like vesicles was investigated at two different pH values (pH 7.4 and 5.3). There is a relatively rapid release in the first stage, followed by a sustained and slow release over a prolonged period of time up to 9 days. Moreover, the doxorubicin release rate at pH 5.3 is faster than that Reprinted with permission from [58] .
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future science group Review Fattahi, Laurent, Liu, Arsalani, Vander Elst & Muller at pH 7.4 for crosslinked and noncrosslinked worm-like vesicles. The authors have attributed this to the reprotonation of the amino group of doxorubicin and faster degradation of the vesicle membrane at low pH value. This pH-dependent release behavior is of particular interest in achieving tumor-targeted doxorubicin delivery with vesicles. It is expected that most of the loaded drug will remain in the vesicle for a considerable period of time during circulation in the bloodstream, where the pH is approximately 7.4. Faster doxorubicin release occurs once the vesicles are taken up by the tumor cell via folate receptor-mediated endocytosis, therby i mproving the efficacy of targeted c ancer therapy [82] .
It is evident that considering this tumor specificity and high r 2 relaxivity of worm-like vesicles, they are good candidates for tumor theragnostics. However, it seems these systems need to be modified further, because doxorubicin, although by low rate, can be released during diagnosis. Since doxorubicin can cause cardiotoxicity, administering doxorubicin-carrying liposome to a patient who is then diagnosed to be tumor-free is unethical and may violate premum non nocere.
So, it would be ideal if the vesicles could be designed in such a way that a trigger, such as heating or light, initiates therapy only after the pathological tissue has been diagnosed.
MLs toxicity
The boom of nanoparticle use in medical applications during the past decade has concomitantly shifted the attention of many researchers towards studying nanoparticle toxicity [83] . In the case of iron oxide nanoparticles, which are widely used as MRI contrast agents, they should not show any sign of cytotoxicity or affect cellular physiology. An interesting and complete review on cytotoxicity assessment of iron oxide nanoparticles based on the ML model has been published by Soenen et al. [84] . In this review, the commonly used assays are presented in order to assess the advantages and disadvantages of AC magnetic field-induced hyperthermia and drug release Figure 11 . Multifunctional magnetoliposomes for cancer theragnostics. The multifunctional drug carrier is a folate receptor-targeted temperature-sensitive magnetoliposome containing doxorubicin, which can be targeted physically by a magnetic field and biologically by folic acid to tumor cells. Drug release will be triggered by hyperthermia upon local application of an AC magnetic field on the tumor tissue. PEG: Polyethylene glycol.
Reprinted with permission from [74] .
Magnetoliposomes as contrast agents for molecular imaging & cancer nanotheragnostics Review several aspects, such as cell viability, induction of reactive oxygen species, nanoparticle uptake, cellular morphology, cellular proliferation, actin cytoskeleton architecture and d ifferentiation of stem cells. As mentioned before, several problems of iron oxide nanoparticles concerning cytotoxicity can be circumvented using phospholipids as coating materials, since phospholipids are biocompatible [85, 86] , bind strongly to the particle surface [15] , and are degraded at a slower rate [19] . For enhancing the cellular uptake of MLs, cationic lipids are incorporated in the outer leaflet of the ML bilayer [27] . Considering the intrinsic cytotoxicity of cationic lipids [87] , much attention should be paid to toxic effects. Different cationic lipid types and concentrations have been tested for optimizing the conditions for labeling of 3T3 fibroblasts with MLs, with the finding that high uptake efficiency was only achieved with MLs that carry a high payload of dioleoyl trimethylammonium propane. However, these structures demonstrated toxic effects. The use of distearoyltrimethylammonium propane at identical concentrations led to improved uptake efficiency and lower toxicity. By using iron oxide-free vesicles, it was shown that the toxicity was due to lipid bilayer c onstituents and not the iron oxide [27] .
It has been shown that endosomal localization of different iron oxide particles results in their degradation and reduced MR contrast, the rate of which is governed mainly by the stability of the coating [88] . In this study, four different kinds of iron oxide-based MRI contrast agents, including Endorem ® , Resovist ® , very small organic particles (VSOP; citrate coated) and cationic MLs, were studied. The results show that, although none of the nanoparticles tested were completely resistant to degradation, the extent of the effects varied greatly between different particles. For in vivo MRI, where the amount of cellular iron is diluted exponentially upon cell divisions, high initial concentrations of iron oxide cores are beneficial for enhancing signal contrast and will allow longer in vivo visualization of the cells after transplantation [89] . Among the tested particles, cationic MLs were the most resistant to degradation owing to their unique features, which result in stable shielding of the iron oxide core by the strongly bound inner lipid layer. Using PLA 2 phospho lipase, degradability tests on ML coating show a clear degradation of the outer lipid layer, whereas the inner lipid layer remains intact. This resulted in monolayercoated iron oxide particles with a hydrophobic surface, which, by clustering in an aqueous environment, significantly enhances their MRI detectability and the labeling efficiency of rapidly proliferating cells, such as C17.2 neural progenitor cells (Figure 13 ) [88] . When cells were labeled with Endorem or MLs, reaching identical intracellular iron levels, Endorem-labeled cells showed fewer Prussian blue-positive nanoparticles than ML-treated cells after 1 week. After 2 weeks, no Endorem particles could be detected, whereas large ML clusters could still be observed (Figure 13F ). This highlights the high stability of the MLs against intracellular degradation and makes these particles more suitable for long-term detection of labeled cells.
Several factors, such as the nature of the cationic lipid and its concentration, the nature of the accompanying neutral matrix host lipids, the size of the lipid vesicles and the presence of a stabilizing nanocore, have been shown to influence the cytotoxic effects of cationic MLs [90, 91] . Nevertheless, some cationic lipid incorporated MLs have been designed that promote internalization without inducing any cytotoxic Reprinted with permission from [82] .
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MLs, with no effect on cell viability. At high intracellular nanoparticle concentrations, it was observed that the particles interfered with the cytoskeleton architecture, leading to a transient reduction in proliferative capacity. These findings suggest that high levels of noncytotoxic nanoparticle uptake induce cellular stress and, as such, nanoparticle uptake seems to be limited in a concentration-dependent manner [92] .
future science group More recently, Soenen et al. investigated the effect of nanoparticle concentration on cell morphology, cytoskeleton, proliferation, reactive oxygen species, functionality, viability and cellular homeo stasis [93] . The authors tested four different types of iron oxide nanoparticles: dextran-coated Endorem, carboxydextran-coated Resovist, lipid-coated MLs and citrate-coated VSOPs. By determining the safe concentration for every particle type, they showed that MLs can lead up to 67.37 ± 5.98 pg Fe per cell, whereas VSOPs are the most toxic particles and only reach 18.65 ± 2.07 pg Fe/cell. Using these safe concentrations, the effect of the nanoparticles on MR contrast generation of labeled cells was investigated (Figure 14) . It was shown that up to 500 cells/µl labeled with VSOPs were required for efficient visualization in an agar phantom, whereas Endorem and Resovist required 200 cells/µl, and MLs only 50 cells/µl [93] .
Conclusion
Molecular imaging is an emerging technology that is set to revolutionize our understanding and treatment of disease. The tools of molecular imaging are the imaging modalities and their corresponding contrast agents; each technique with its own advantages and disadvantages. To overcome the limitations of individual imaging modalities, multimodal imaging techniques have been developed. An important challenge in this field is to design all-in-one contrast agents that can be detected with multiple imaging techniques. Owing to their flexibility and ease of preparation, MLs can be carefully manipulated in their composition to incorporate cationic lipids, fluorescent-lipid conjugates, targeting ligands and PEG; containing all in a single nanosystem that can be used as an efficient multimodal contrast agent. In addition, owing to their biocompatibility, functionality and potential for combining drug delivery and imaging, MLs are a versatile platform for theragnostics. Considering the potential applicability of iron oxide nanoparticles in hyperthermia cancer treatment, the structure of MLs offers a very efficient platform to combine both chemotherapy and hyperthermia cancer treatment with the ability to monitor the therapy efficiency with different imaging techniques.
Future perspective
This article has sought to explain the preparation of different MLs, their possible use as multimodal contrast agents, as well as their application for theragnostics and their cytotoxic aspects. Owing to their unique structure, MLs have appeared as a new and interesting platform that can combine different cancer therapeutic and imaging agents all in one system, known as nanotheragnostics. In this way the therapeutic agents can be directed to the target tissue either by applying an external magnetic field or by the targeting ligands anchored on the MLs; hence, a more efficient targeting is possible. Further research is required to obtain MLs for application to hyperthermia. This research includes, on one hand, future science group Review Fattahi, Laurent, Liu, Arsalani, Vander Elst & Muller preparation of MLs with tunable and monodispersed iron oxide nanoparticles in the core, to increase their efficiency, and on the other hand, preparation of MLs with a thermosensitive lipid bilayer, which would allow a more accurate drug release. Different materials and strategies can be examined to obtain new conjugated MLs as multimodal contrast agents for use in new combined imaging modalities. Further studies on the mechanism of cellular interaction of MLs, as well as the possible c ytotoxic effects, are also necessary.
